Screen

Proprietary screen to select molecules, products, ingredients with:
 
  • anti-inflammatory activity,
  • with ability to inhibit oxidative damage specific for the inflammatory environment,
  • anti-hypoxic properties,
  • anti-protease activity, anti-catabolic properties

Formulation

Using proprietary technologies Lycotec can:

 
  • enhance bioavailability of selected molecules and
  • adapt the improved formulas for nutraceutical, food or beverage matrixes

Development

Using proprietary tests to verify activity:

 
  • in vitro assays
  • in cell cultures
  • ex vivo on operation material and biopsies obtain from partner clinics

Analytical

 
  • lycopene, lutein, zeaxanthin, astaxanthin, α – and β-carotene, cryptoxanthin, coenzyme Q10, anthocyanins, epicatechins, caffeine, theobromine, serotonin, phenylethylamine, trans-resveratrol, DHA and EPA Omega 3 in different food matrixes, beverages, blood plasma, tissue biopsy

Clinical Validation

 
  • quantity and quality of sebum
  • rate of exfoliation and level of damage of corneocytes
  • bacterial skin load
  • lycopene measurement in sebum and corneocytes for detection and correction of lycopene deficiencies

Non-Invasive Diagnostics

Network of laboratories and clinics in Europe, US, Russia and Middle East to:

 
  • develop and clinically validate new neutraceutical and functional food products
  • tailor and adapt their applications for specific ethnic groups
  • anti-hypoxic properties,
  • anti-protease activity, anti-catabolic properties

LYCOTEC NEWSLETTER

Subscribe now and receive publications newsletter from us!

 
 

© 2010 – 2018 Copyright Lycotec Limited. Registered in England and Wales No: 6527761.